Screening and Detection of Hepatocellular Carcinoma
- 1 May 2015
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 19 (2) , 295-307
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysisHepatology International, 2012
- Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysisBMC Cancer, 2012
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular CarcinomaGastroenterology, 2009
- Structural and functional mapping of α-fetoproteinBiochemistry (Moscow), 2006
- GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinomaJournal of Hepatology, 2005
- Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C TrialJournal of Hepatology, 2005
- Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre studyGut, 2004
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusJournal of Hepatology, 2001